Genetic testing for suspected lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at genetic changes in people with suspected or high-risk lung cancer. It aims to use those results to guide more personalized treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must be scheduled for a bronchoscopy or lung surgery as part of your standard care.
- You must be considered at moderate or high risk for lung cancer, or have suspected spread of the disease.
- You must be willing to provide blood or saliva samples and allow testing of any stored tumor tissue.
- You must not have had extensive genetic testing (more than 40 genes in blood or more than 250 genes in tumor) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
This study looks at inherited genetic changes in people with a type of lung cancer called lung adenocarcinoma. The goal is to find gene variants linked to the disease, which may help guide future treatment decisions.
This trial is part of a lung cancer network that uses genetic (DNA) testing to better understand and treat non-surgical lung cancer. You might be eligible if you have certain stages of non-small cell lung cancer and can consent to participate.
This study looks for inherited (family-passed) genetic changes that may raise the risk of lung cancer and related thoracic cancers. It may help people and families understand their genetic risk by collecting health information and sometimes specimens from patients and relatives.
This study looks at lung cancer tumor tissue to find genetic “on/off” changes and why treatments may stop working. It may help your care team choose better next tests or treatments based on what the tumor is doing.
Hear when a new Metastatic Malignant Neoplasm in the Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.